- Home
- SOHU vs AURA Comparison
SOHU vs AURA Comparison
Compare SOHU & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOHU
- AURA
- Stock Information
- Founded
- SOHU 1996
- AURA 2007
- Country
- SOHU China
- AURA United States
- Employees
- SOHU N/A
- AURA N/A
- Industry
- SOHU EDP Services
- AURA Biotechnology: Pharmaceutical Preparations
- Sector
- SOHU Technology
- AURA Health Care
- Exchange
- SOHU Nasdaq
- AURA Nasdaq
- Market Cap
- SOHU 468.1M
- AURA 396.8M
- IPO Year
- SOHU 2000
- AURA 2021
- Fundamental
- Price
- SOHU $15.77
- AURA $6.10
- Analyst Decision
- SOHU Strong Buy
- AURA Strong Buy
- Analyst Count
- SOHU 1
- AURA 7
- Target Price
- SOHU $20.00
- AURA $22.29
- AVG Volume (30 Days)
- SOHU 71.7K
- AURA 172.4K
- Earning Date
- SOHU 11-11-2025
- AURA 11-11-2025
- Dividend Yield
- SOHU N/A
- AURA N/A
- EPS Growth
- SOHU N/A
- AURA N/A
- EPS
- SOHU 4.10
- AURA N/A
- Revenue
- SOHU $548,588,000.00
- AURA N/A
- Revenue This Year
- SOHU N/A
- AURA N/A
- Revenue Next Year
- SOHU $2.29
- AURA N/A
- P/E Ratio
- SOHU $3.82
- AURA N/A
- Revenue Growth
- SOHU N/A
- AURA N/A
- 52 Week Low
- SOHU $7.79
- AURA $4.35
- 52 Week High
- SOHU $17.24
- AURA $12.38
- Technical
- Relative Strength Index (RSI)
- SOHU 52.34
- AURA 41.43
- Support Level
- SOHU $15.49
- AURA $5.89
- Resistance Level
- SOHU $16.21
- AURA $6.52
- Average True Range (ATR)
- SOHU 0.49
- AURA 0.31
- MACD
- SOHU -0.08
- AURA -0.03
- Stochastic Oscillator
- SOHU 38.74
- AURA 25.27
About SOHU Sohu.com Limited
Sohu.com Ltd provides online media, games, and search products and services on PCs and mobile devices in China. The company operates in Sohu and Changyou segments. Sohu is an online media content and services provider. Through its social features, Sohu also enables users to generate and distribute content, as well as interact with each other on a platform. Changyou is an online game developer and operator. It generates maximum revenue from the Changyou segment.
About AURA Aura Biosciences Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.